Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:47pm, Tuesday, 31'st Oct 2023
In the most recent trading session, Amphastar Pharmaceuticals (AMPH) closed at $45.27, indicating a +0.2% shift from the previous trading day.
Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why
07:34pm, Monday, 30'th Oct 2023
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $45.19, representing a +1.23% change from its previous close.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:17am, Monday, 30'th Oct 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.
Amphastar Pharmaceuticals (AMPH) Rises As Market Takes a Dip: Key Facts
07:33pm, Monday, 23'rd Oct 2023
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $44.72, denoting a +0.52% change from the preceding trading day.
Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why
07:33pm, Monday, 16'th Oct 2023
Amphastar Pharmaceuticals (AMPH) closed at $46.47 in the latest trading session, marking a +1.55% move from the prior day.
Amphastar Pharmaceuticals: Great Growth At A High Price
09:41pm, Tuesday, 10'th Oct 2023
Amphastar Pharmaceuticals has implemented aggressive corporate strategies to maximize margins and increase sales, resulting in impressive EBIT and revenue growth. The company's focus on high-margin pr
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
11:17am, Tuesday, 10'th Oct 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.
Amphastar Pharmaceuticals (AMPH) Rises Higher Than Market: Key Facts
07:32pm, Monday, 09'th Oct 2023
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $47.55, denoting a +0.76% change from the preceding trading day.
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
04:05pm, Thursday, 31'st Aug 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operati
Amphastar Pharma (AMPH) Stock Skyrockets 89% YTD: Here's Why
03:34pm, Friday, 18'th Aug 2023
Amphastar Pharma (AMPH) shares are up 89.1% year to date due to the acquisition of Baqsimi from Lilly. The company also receives FDA approval for Naloxone.
Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:47pm, Friday, 11'th Aug 2023
Amphastar (AMPH) could produce exceptional returns because of its solid growth attributes.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
12:17pm, Friday, 11'th Aug 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to AMPH, RDY and TEVA.
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
09:56pm, Tuesday, 08'th Aug 2023
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.39 per share a year ago.
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2023 Earnings Call Transcript
08:35pm, Tuesday, 08'th Aug 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications Bill Pet
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
04:10pm, Wednesday, 02'nd Aug 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2023 ended June 30, 2023, a
